Detailed information for compound 1712136

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 338.375 | Formula: C20H19FN2O2
  • H donors: 2 H acceptors: 2 LogP: 4.09 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc(cc1)[C@H]1O[C@H](CCc2ccccc2)Cc2c1c(O)[nH]n2
  • InChi: 1S/C20H19FN2O2/c21-15-9-7-14(8-10-15)19-18-17(22-23-20(18)24)12-16(25-19)11-6-13-4-2-1-3-5-13/h1-5,7-10,16,19H,6,11-12H2,(H2,22,23,24)/t16-,19-/m1/s1
  • InChiKey: IZNJIUCXCSSYRS-VQIMIIECSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni hypothetical protein 0.0166 1 1
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.006 0.1523 0.2612
Schistosoma mansoni serine/threonine protein kinase 0.0114 0.5828 0.5828
Trichomonas vaginalis CAMK family protein kinase 0.0114 0.5828 1
Schistosoma mansoni hypothetical protein 0.0166 1 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 0.1523 0.2612
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0114 0.5828 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0114 0.5828 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 0.1523 0.2612
Trypanosoma brucei polo-like protein kinase 0.0114 0.5828 0.5
Schistosoma mansoni tar DNA-binding protein 0.0076 0.2825 0.2825
Schistosoma mansoni tar DNA-binding protein 0.0076 0.2825 0.2825
Trichomonas vaginalis CAMK family protein kinase 0.0114 0.5828 1
Entamoeba histolytica serine/threonine protein kinase, putative 0.0114 0.5828 1
Loa Loa (eye worm) hypothetical protein 0.006 0.1523 0.2612
Brugia malayi serine/threonine-protein kinase plk-2 0.0114 0.5828 1
Schistosoma mansoni kinase 0.0058 0.1344 0.1344
Schistosoma mansoni tar DNA-binding protein 0.0076 0.2825 0.2825
Loa Loa (eye worm) TAR-binding protein 0.0076 0.2825 0.4847
Trypanosoma cruzi polo-like protein kinase, putative 0.0114 0.5828 0.5
Loa Loa (eye worm) RNA binding protein 0.0076 0.2825 0.4847
Onchocerca volvulus Serine\/threonine kinase homolog 0.0114 0.5828 0.5
Schistosoma mansoni tar DNA-binding protein 0.0076 0.2825 0.2825
Trichomonas vaginalis CAMK family protein kinase 0.0114 0.5828 1
Schistosoma mansoni tar DNA-binding protein 0.0076 0.2825 0.2825
Echinococcus multilocularis serine:threonine protein kinase PLK1 0.0114 0.5828 0.4186
Echinococcus multilocularis geminin 0.0166 1 1
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0114 0.5828 1
Echinococcus granulosus serine:threonine protein kinase PLK1 0.0114 0.5828 0.4186
Trichomonas vaginalis CAMK family protein kinase 0.0114 0.5828 1
Giardia lamblia Kinase, PLK 0.0114 0.5828 0.5
Brugia malayi TAR-binding protein 0.0076 0.2825 0.4847
Loa Loa (eye worm) hypothetical protein 0.0081 0.3188 0.5469
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0076 0.2825 0.4847
Trichomonas vaginalis CAMK family protein kinase 0.0114 0.5828 1
Trypanosoma cruzi polo-like protein kinase, putative 0.0114 0.5828 0.5
Brugia malayi RNA binding protein 0.0076 0.2825 0.4847
Trichomonas vaginalis CAMK family protein kinase 0.0114 0.5828 1
Brugia malayi RNA recognition motif domain containing protein 0.0076 0.2825 0.4847

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 28.1838 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.